Literatura académica sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
Farzanehpour, Mahdieh, Amir M. M. Fard y Hadi E. G. Ghaleh. "A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma". Romanian Journal of Military Medicine 125, n.º 3 (1 de agosto de 2022): 373–81. http://dx.doi.org/10.55453/rjmm.2022.125.3.4.
Texto completoShah, K. M. y L. S. Young. "Epstein–Barr virus and carcinogenesis: beyond Burkitt's lymphoma". Clinical Microbiology and Infection 15, n.º 11 (noviembre de 2009): 982–88. http://dx.doi.org/10.1111/j.1469-0691.2009.03033.x.
Texto completoOkano, M., G. M. Thiele, J. R. Davis, H. L. Grierson y D. T. Purtilo. "Epstein-Barr virus and human diseases: recent advances in diagnosis." Clinical Microbiology Reviews 1, n.º 3 (julio de 1988): 300–312. http://dx.doi.org/10.1128/cmr.1.3.300.
Texto completoTosato, G., C. Sgadari, K. Taga, KD Jones, SE Pike, A. Rosenberg, JM Sechler, IT Magrath, LA Love y K. Bhatia. "Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells". Blood 83, n.º 3 (1 de febrero de 1994): 776–84. http://dx.doi.org/10.1182/blood.v83.3.776.776.
Texto completoTosato, G., C. Sgadari, K. Taga, KD Jones, SE Pike, A. Rosenberg, JM Sechler, IT Magrath, LA Love y K. Bhatia. "Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells". Blood 83, n.º 3 (1 de febrero de 1994): 776–84. http://dx.doi.org/10.1182/blood.v83.3.776.bloodjournal833776.
Texto completoStebbing, Justin y Mark Bower. "Epstein-Barr virus in Burkitt's lymphoma: the missing link". Lancet Oncology 10, n.º 4 (abril de 2009): 430. http://dx.doi.org/10.1016/s1470-2045(09)70045-2.
Texto completoKamranvar, S. A., B. Gruhne, A. Szeles y M. G. Masucci. "Epstein–Barr virus promotes genomic instability in Burkitt's lymphoma". Oncogene 26, n.º 35 (26 de febrero de 2007): 5115–23. http://dx.doi.org/10.1038/sj.onc.1210324.
Texto completoGoldstein, J. A. y R. L. Bernstein. "Burkitt's Lymphoma and the Role of Epstein-Barr Virus". Journal of Tropical Pediatrics 36, n.º 3 (1 de junio de 1990): 114–20. http://dx.doi.org/10.1093/tropej/36.3.114.
Texto completoJoob, Beuy y Viroj Wiwanitkit. "Malaria, Epstein-Barr virus, vitamin A and Burkitt's lymphoma". International Journal of Cancer 142, n.º 4 (31 de octubre de 2017): 863. http://dx.doi.org/10.1002/ijc.31118.
Texto completoSánchez-Giler, Sunny, Alan Herrera-Vásquez, Claudia Castillo-Zambrano, Luis Solórzano-Alava, Dolores Zambrano-Castro, Cristina Kuon-Yeng, Alba Silva-Orellana, Juan Murillo-Zambrano y Genaro Cucalón-González. "Detección del Virus de Epstein-Barr en linfoma mediante qPCR //Detection of Epstein-Barr Virus (EBV) in lymphoma through qPCR". Ciencia Unemi 11, n.º 26 (5 de junio de 2018): 126. http://dx.doi.org/10.29076/issn.2528-7737vol11iss26.2018pp126-133p.
Texto completoTesis sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
MUNDO, LUCIA. "Infectious agents and cancer: A look into EBV pathways involved in the transition from infection to lymphomagenesis". Doctoral thesis, Università di Siena, 2017. http://hdl.handle.net/11365/1012697.
Texto completoDonati, Daria. "Malaria, B lymphocytes and Epstein-Barr virus : emerging concepts on Burkitt's lymphoma pathogenesis /". Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-403-1/.
Texto completoKaymaz, Yasin. "Genomic and Transcriptomic Investigation of Endemic Burkitt Lymphoma and Epstein Barr Virus". eScholarship@UMMS, 2017. https://escholarship.umassmed.edu/gsbs_diss/914.
Texto completoKaymaz, Yasin. "Genomic and Transcriptomic Investigation of Endemic Burkitt Lymphoma and Epstein Barr Virus". eScholarship@UMMS, 2007. http://escholarship.umassmed.edu/gsbs_diss/914.
Texto completoAmoroso, Richard Benjamin Couture. "Studies on the expression and function of Epstein-Barr virus encoded microRNAs in Burkitt lymphoma". Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/3694/.
Texto completoBoyce, Andrew John. "Epstein-Barr virus genome loss from endemic Burkitt lymphoma and its effect on cell phenotype". Thesis, University of Birmingham, 2009. http://etheses.bham.ac.uk//id/eprint/4731/.
Texto completoLeung, Yuen-ying y 梁婉瑩. "Effects of histone deacetylase and proteasome inhibitors on Epstein-barr virus-positive Burkitt lymphoma and lymphoblastoid cells". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/207474.
Texto completopublished_or_final_version
Paediatrics and Adolescent Medicine
Master
Master of Philosophy
Rao, Sieta Padmaja. "Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells /". [S.l.] : [s.n.], 2008. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000253262.
Texto completoImreh, Marta P. "Modulation of cellular and viral functions in Epstein-Barr virus infected cells /". Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-171-3.
Texto completoCherdoud-Chelouah, Sonia. "Rôle fonctionnel de la protéine de latence EBNA-LP exprimée dans les cellules de lymphome de Burkitt infectées par la souche P3HR1 du virus d’Epstein-Barr". Thesis, Paris 11, 2012. http://www.theses.fr/2012PA11T023.
Texto completoOur group has previously shown that Burkitt’s lymphoma (BL) cells infected by the P3HR1 variant of Epstein-Barr virus (EBV) are more resistant to apoptotsis than EBV (-) BL cells or cells infected by wild-type EBV. The genome of the P3HR1 variant carries a deletion responsible for the expression of a truncated form of EBNA-LP (tEBNA-LP). We studied the functional role of tEBNA-LP in BL cells infected by the P3HR1 variant. A proteomic study allow us to identify cellular and viral partners of tEBNA-LP. These results confirmed the interaction between tEBNA-LP and PP2A, already established by our group, and showed that tEBNA-LP can form complexes with other proteins involved in many cellular processes including apoptosis and regulation of transcription. We have then demonstrated by a transcriptomic study, the transcriptional regulatory role of both forms of EBNA-LP stably expressed in EBV(-) BL cell lines. Indeed, we showed that both forms of EBNA-LP can regulate the expression of cellular genes independently of viral context. Some of these genes are common to both forms of EBNA-LP, others are specific to each form. We found that Y1Y2 domaine of EBNA-LP is essential to overexpression of the cellular gene encoding ID1 protein which is involved in LMP1 stabilization and cellular mmortalization. We also noted that some genes are similarly regulated in the presence of EBNA-LP alone or in the presence of viral genome. Finally, to better undertand the mecanisms of resistance to apoptosis in BL cell lines infected by the P3HR1 variant we extended our transcriptomic analysis to cell lines treated or not with an apoptosis inducer, cycloheximide. Our preliminary results show that TNF receptors signaling pathways (TNFR1 and 2) are rapidly and strongly induced in sensitive cell lines while being weakly and belatedly induced in the resistant cell lines. This study also shows that the JNK signaling pathway is probably activated very early in the sensitive cells in contrast to resistant cell lines
Libros sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
ed, Epstein M. A. y Achong, B. G., 1928- ed., eds. The Epstein-Barr virus: Recent advances. New York: Wiley, 1986.
Buscar texto completoA, Epstein M. y Achong B. G. 1928-, eds. The Epstein-Barr virus: Recent advances. New York: J. Wiley, 1986.
Buscar texto completoLindholm, Carita. Contribution of Epstein-Barr virus genes to Burkitt's lymphoma phenotype. Birmingham: University of Birmingham, 1989.
Buscar texto completoBianca, Leonardo, ed. A holistic protocol for the immune system: HIV/ARC/AIDS, candidiasis, Epstein-Barr, herpes, and other opportunistic infections. Palm Springs, CA: Tree of Life Publications, 1989.
Buscar texto completoM. A. Epstein (Other Contributor) y B. G. Achong (Other Contributor), eds. The Epstein-Barr virus: Recent advances (A Wiley medical publication). J. Wiley, 1986.
Buscar texto completoKeane, Maccon M. Epstein-Barr virus and lymphocyte morphology in lymphoma. 1995.
Buscar texto completoMacMahon, Eithne Mary Edana. Epstein-Barr virus and AIDS-related primary CNS lymphoma. 1996.
Buscar texto completoGregory, Scott J. A Holistic Protocol for the Immune System: HIV/ARC/AIDS/Candidiasis/Epstein-Barr/Herpes and other opportunistic infections. 6a ed. Progressive Press, 1995.
Buscar texto completoScott, Gregory J. y Scott Gregory. A Holistic Protocol for the Immune System: HIV/ARC/AIDS, Candidiasis, Epstein-Barr, Herpes, and Other Opportunistic Infections. Progressive Press, 1991.
Buscar texto completo(Contributor), WHO, ed. Epstein-Barr Virus and Kaposi's Sarcoma Herpes Virus/Human Herpesvirus 8 (IARC Monographs on Eval of Carcinogenic Risk to Humans). World Health Organisation, 1997.
Buscar texto completoCapítulos de libros sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
Banerjee, Shuvomoy, Hem Chandra Jha, Qiliang Cai y Erle S. Robertson. "Epstein–Barr Virus and Burkitt’s Lymphoma". En Burkitt’s Lymphoma, 175–209. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-4313-1_10.
Texto completode Thé, Guy. "Epstein-Barr Virus and Burkitt’s Lymphoma". En Infectious Causes of Cancer, 77–92. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-024-7_5.
Texto completoWiels, J., E. H. Holmes, N. Cochran, S. I. Hakomori y T. Tursz. "Mechanisms of Expression of a Burkitt Lymphoma-Associated Antigen (Globotriaosylceramide) in Burkitt Lymphoma and Lymphoblastoid Cell Lines". En Epstein-Barr Virus and Associated Diseases, 588–99. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2625-0_55.
Texto completoTakada, K. "Role of Epstein-Barr Virus in Burkitt’s Lymphoma". En Current Topics in Microbiology and Immunology, 141–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56515-1_9.
Texto completoItakura, Hideyo y Kan Toriyama. "Geopathological Coincidence of Burkitt’s Lymphoma and Endemic Kaposi’s Sarcoma in Western Kenya". En Epstein-Barr Virus and Human Disease, 453–54. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_97.
Texto completoMagrath, Ian T. "Clinical and Pathobiological Features of Burkitt’s Lymphoma and their Relevance to Treatment". En Epstein-Barr Virus and Associated Diseases, 631–43. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2625-0_58.
Texto completoNkrumah, F. K., G. Pizza, D. Viza, J. Neequaye, C. De Vinci y P. H. Levine. "EBV-Specific Transfer Factor in the Treatment Of African Burkitt’s Lymphoma: A Pilot Study". En Epstein-Barr Virus and Associated Diseases, 666–72. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2625-0_61.
Texto completoRooney, Cliona M., M. Brimmell, G. Allan, P. Farrell y M. Buschle. "EBNA-2 Influences Promoter Function in Burkitt Lymphoma Cells". En Epstein-Barr Virus and Human Disease • 1990, 65–67. Totowa, NJ: Humana Press, 1991. http://dx.doi.org/10.1007/978-1-4612-0405-3_9.
Texto completoNeequaye, J., G. Pizza, D. Viza, C. de Vinci, P. H. Levine y F. K. Nkrumah. "Ebv-Specific Transfer Factor in the Treatment of Abdominal Burkitt’s Lymphoma in Ghana, West Africa". En Epstein-Barr Virus and Human Disease, 503–7. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_107.
Texto completoCrawford, D. H. y M. G. Doyle. "Stimulation of EB Virus-Specific Helper T Cells by Burkitt’s Lymphoma and Lymphblastoid Cell Lines". En Epstein-Barr Virus and Human Disease, 393–94. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_83.
Texto completoActas de conferencias sobre el tema "Epstein-Barr Virus Burkitt's Lymphoma"
El-Mallawany, Nader Kim, Janet Ayello, Nancy Day, Carmella Van de Ven, Matthew Benson, Kevin Conlon, Damian Fermin et al. "Abstract 1199: Global proteomic evaluation of the relationship between Epstein-Barr virus (EBV) and c-myc deregulation in endemic versus sporadic Burkitt lymphoma (BL)". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1199.
Texto completoRasim, K., S. Suttner, M. Vogelhuber, W. Herr, A. Gessner, B. Seelbach-Goebel y E. Reuschel. "Epstein-Barr-Virus (EBV)-assoziiertes Burkitt-Lymphom in der Schwangerschaft". En Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1718347.
Texto completoRouce, Rayne H., Serena K. Perna, Gayatri Vyas, Sandhya Sharma, Natalia Lapteva, Ann Leen, Cliona M. Rooney y Helen E. Heslop. "Abstract B17: Banked Epstein-Barr virus specific T-cells for treatment of EBV+ lymphoma". En Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-b17.
Texto completoPereira, V., S. Boudjemaa, C. Besson, P. Simon, T. Leblanc y J. Landman-Parker. "Epstein Barr Virus in children and adolescents with classical Hodgkin Lymphoma: analysis of a cohort of 299 patients". En ISCAYAHL 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1701828.
Texto completoJain, Nitesh K., Hasnain S. Bawaadam, Aman Sethi, Ashok Fulambarker, Peter Morawiecki y Rashid Nadeem. "Epstein-Barr Virus Associated Diffuse Large B-Cell Lymphoma Presenting As A Lung Mass In An Immunocompetent Patient". En American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4393.
Texto completoBolanos, Rachel, Amie Hwang, Jose Aparicio, Chun Chao, Naba Qurashi, Christopher Flowers, Sheeja Pullarkat et al. "Abstract B092: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors by race/ethnicity in a multiethnic U.S. population". En Abstracts: Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 20-23, 2019; San Francisco, CA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp19-b092.
Texto completoChao, Chun R., Donald Abrams, Michael J. Silverberg, Reina Haque, Hongbin D. Zha, Otoniel Martinez-Maza, Michelle McGuire et al. "Abstract 4643: Epstein-Barr virus infection (EBV) and expression of B-cell oncogenic markers in HIV+ diffuse large B-cell lymphoma (DLBCL)". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4643.
Texto completoVilimas, Tomas, Gloryvee Rivera, Brandie Fullmer, Wiem Lassoued, Lindsay Dutko, William Walsh, Amanda Peach et al. "Abstract 1038: Xenograft-associated B cell lymphoproliferative disease as a surrogate model to study Epstein-Barr virus (EBV) driven lymphoma of the elderly". En Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1038.
Texto completoBolanos, Rachel, Amie Hwang, Chun Chao, Christopher Flowers, Sheeja Pullarkat, Jose Aparicio, Sophia Wang et al. "Abstract 5053: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-5053.
Texto completoBolanos, Rachel, Amie Hwang, Chun Chao, Christopher Flowers, Sheeja Pullarkat, Jose Aparicio, Sophia Wang et al. "Abstract 5053: Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-5053.
Texto completo